Literature DB >> 3605386

Adaptation of circadian rhythmicity to shift in light-dark cycle accelerated by a benzodiazepine.

O van Reeth, F W Turek.   

Abstract

The light-dark cycle is the major synchronizing agent for circadian rhythms in animals. After an abrupt shift in the light-dark cycle, it usually takes many days for circadian rhythms to resynchronize. A single injection of the short-acting benzodiazepine, triazolam, to hamsters subjected to an 8-h advance of the light-dark cycle resulted in an approximately 50% reduction in the time taken for the circadian locomotor activity rhythm to be resynchronized to the new lighting schedule. These results suggest that it may be possible to use drugs to facilitate the resynchronization of human circadian rhythms following an abrupt change in environmental time.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3605386     DOI: 10.1152/ajpregu.1987.253.1.R204

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Can pharmacological agents be used effectively in the alleviation of jet-lag?

Authors:  P H Redfern
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

2.  Brief constant light accelerates serotonergic re-entrainment to large shifts of the daily light/dark cycle.

Authors:  G Kaur; R Thind; J D Glass
Journal:  Neuroscience       Date:  2009-02-13       Impact factor: 3.590

3.  Effects of midazolam on sleep disturbances associated with westward and eastward flights: evidence for directional effects.

Authors:  P Lavie
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Melatonin accelerates reentrainment of the circadian rhythm of its own production after an 8-h advance of the light-dark cycle.

Authors:  H Illnerová; G P Trentini; L Maslova
Journal:  J Comp Physiol A       Date:  1989-11       Impact factor: 1.836

5.  Single injections of triazolam, a short-acting benzodiazepine, lengthen the period of the circadian activity rhythm in golden hamsters.

Authors:  J E Joy; S Losee-Olson; F W Turek
Journal:  Experientia       Date:  1989-02-15

Review 6.  Keep Your Mask On: The Benefits of Masking for Behavior and the Contributions of Aging and Disease on Dysfunctional Masking Pathways.

Authors:  Andrew J Gall; Dorela D Shuboni-Mulligan
Journal:  Front Neurosci       Date:  2022-08-09       Impact factor: 5.152

Review 7.  Pharmacotherapeutic management of insomnia and effects on sleep processes, neural plasticity, and brain systems modulating stress: A narrative review.

Authors:  Laura Palagini; Carlotta Bianchini
Journal:  Front Neurosci       Date:  2022-07-29       Impact factor: 5.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.